An insufficient number of examined lymph nodes may offset the survival benefit from neoadjuvant therapy in esophageal squamous cell carcinoma

Yang Yu-Shang; Hu Wei-Peng; Wang Wen-Ping; Yuan Yong; Chen Long-Qi

首页> 外文期刊>Surgery >An insufficient number of examined lymph nodes may offset the survival benefit from neoadjuvant therapy in esophageal squamous cell carcinoma

【24h】

An insufficient number of examined lymph nodes may offset the survival benefit from neoadjuvant therapy in esophageal squamous cell carcinoma

机译：所检查的淋巴结数量不足可能抵消食管鳞状细胞癌中新辅助治疗的生存益处

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Surgery》 |2019年第3期|共1页
作者
Yang Yu-Shang; Hu Wei-Peng; Wang Wen-Ping; Yuan Yong; Chen Long-Qi;
展开▼
作者单位

Sichuan Univ West China Hosp Dept Thorac Surg Chengdu Sichuan Peoples R China;

Sichuan Univ West China Hosp Dept Thorac Surg Chengdu Sichuan Peoples R China;

Sichuan Univ West China Hosp Dept Thorac Surg Chengdu Sichuan Peoples R China;

Sichuan Univ West China Hosp Dept Thorac Surg Chengdu Sichuan Peoples R China;

Sichuan Univ West China Hosp Dept Thorac Surg Chengdu Sichuan Peoples R China;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类外科学;
关键词

相似文献

外文文献
中文文献
专利

1. An insufficient number of examined lymph nodes may offset the survival benefit from neoadjuvant therapy in esophageal squamous cell carcinoma [J] . Yang Yu-Shang, Hu Wei-Peng, Wang Wen-Ping, Surgery . 2019,第3期

机译：所检查的淋巴结数量不足可能抵消食管鳞状细胞癌中新辅助治疗的生存益处
2. Impact of extracapsular lymph node involvement on tumor progression in esophageal squamous cell carcinoma after neoadjuvant therapy and effects on lymph nodes induced by chemotherapy and chemoradiotherapy [J] . Susumu Saigusa, Yasuhiko Mohri, Koji Tanaka, Esophagus . 2014,第2期

机译：新辅助治疗后食管鳞状细胞癌累及囊外淋巴结对肿瘤进展的影响以及化疗和放化疗对淋巴结的影响
3. SUVmax reduction predicts long-term survival in patients of non-pCR both in the tumor and lymph nodes after neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma [J] . Nagaki Yushi, Motoyama Satoru, Sato Yusuke, World Journal of Surgical Oncology . 2021,第1期

机译：Suvmax降低预测食管鳞状细胞癌中Neoadjuvant ChemoRAdiOurapy后肿瘤和淋巴结患者的非PCR患者的长期存活
4. Neoadjuvant therapy of oesophageal carcinoma and carcinoma of the gastro-oesophageal junction [C] . S. PETRASC Falk Symposium . 2006

机译：Neoadjuvant治疗食管癌癌癌和胃卵食管交配的癌
5. Identification of Novel Candidate Tumor Suppressor Genes at 11q and 15q for Esophageal Squamous Cell Carcinoma and Nasopharyngeal Carcinoma via Integrative Cancer Epigenetics and Genomics. [D] . Li, Jisheng. 2010

机译：通过综合癌症表观遗传学和基因组学鉴定食管鳞状细胞癌和鼻咽癌的11q和15q新型候选肿瘤抑制基因。
6. Supraclavicular and/or celiac lymph node metastases from thoracic esophageal squamous cell carcinoma did not compromise survival following neoadjuvant chemoradiotherapy and surgery [O] . Won Kyung Cho, Dongryul Oh, Yong Chan Ahn, 2017

机译：胸食管鳞状细胞癌的锁骨上和/或腹腔淋巴结转移并未影响新辅助放化疗和手术后的生存
7. Neoadjuvant Chemoradiotherapy Followed by Esophagectomy with Three-Field Lymph Node Dissection for Thoracic Esophageal Squamous Cell Carcinoma Patients with Clinical Stage III and with Supraclavicular Lymph Node Metastasis [O] . Yusuke Sato, Satoru Motoyama, Yuki Wada, 2021

机译：Neoadjuvant ChemorAdiotApiation，随后对胸部食管鳞状细胞癌患者的三场淋巴结解剖，临床阶段III患者和Suprachulary淋巴结转移

An insufficient number of examined lymph nodes may offset the survival benefit from neoadjuvant therapy in esophageal squamous cell carcinoma

著录项

相似文献

相关主题

期刊订阅